Ariel E. Feldstein

34.6k total citations · 15 hit papers
220 papers, 26.9k citations indexed

About

Ariel E. Feldstein is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ariel E. Feldstein has authored 220 papers receiving a total of 26.9k indexed citations (citations by other indexed papers that have themselves been cited), including 171 papers in Epidemiology, 82 papers in Hepatology and 57 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ariel E. Feldstein's work include Liver Disease Diagnosis and Treatment (161 papers), Diet, Metabolism, and Disease (51 papers) and Liver Disease and Transplantation (44 papers). Ariel E. Feldstein is often cited by papers focused on Liver Disease Diagnosis and Treatment (161 papers), Diet, Metabolism, and Disease (51 papers) and Liver Disease and Transplantation (44 papers). Ariel E. Feldstein collaborates with scholars based in United States, Germany and Italy. Ariel E. Feldstein's co-authors include Paul Angulo, Rocío López, Ali Canbay, Naim Alkhouri, Keith D. Lindor, Alexander Wree, Leon A. Adams, Akiko Eguchi, Anna Więckowska and Gregory J. Gores and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Ariel E. Feldstein

215 papers receiving 26.5k citations

Hit Papers

Gut flora metabolism of p... 2003 2026 2010 2018 2011 2005 2017 2003 2013 1000 2.0k 3.0k 4.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
    2011 4.1k citations Ariel E. Feldstein, Philip R. Schauer et al. profile →
  2. The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
    2005 2.2k citations Ariel E. Feldstein et al. profile →
  3. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice
    2017 863 citations Auvro R. Mridha, Alexander Wree et al. Journal of Hepatology profile →
  4. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis
    2003 860 citations Ariel E. Feldstein et al. profile →
  5. NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice
    2013 779 citations Alexander Wree, Akiko Eguchi et al. Hepatology profile →
  6. Triggering and resolution of inflammation in NASH
    2018 681 citations Ariel E. Feldstein et al. profile →
  7. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-α expression via a lysosomal pathway
    2004 655 citations Ariel E. Feldstein et al. Hepatology profile →
  8. The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years
    2009 550 citations Ariel E. Feldstein et al. Gut profile →
  9. Cytokeratin-18 Fragment Levels as Noninvasive Biomarkers for Nonalcoholic Steatohepatitis
    2009 520 citations Ariel E. Feldstein, Nizar N. Zein et al. Hepatology profile →
  10. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease
    2006 509 citations Nizar N. Zein, Ariel E. Feldstein et al. Hepatology profile →
  11. From NAFLD to NASH to cirrhosis—new insights into disease mechanisms
    2013 491 citations Alexander Wree, Lori Broderick et al. profile →
  12. Increased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic Steatohepatitis
    2008 481 citations Nizar N. Zein, Ariel E. Feldstein et al. The American Journal of Gastroenterology profile →
  13. NLRP3 inflammasome activation is required for fibrosis development in NAFLD
    2014 404 citations Alexander Wree, Hal M. Hoffman et al. Journal of Molecular Medicine profile →
  14. Innate Immunity and Inflammation in NAFLD/NASH
    2016 392 citations Ariel E. Feldstein et al. profile →
  15. Dynamic Shifts in the Composition of Resident and Recruited Macrophages Influence Tissue Remodeling in NASH
    2021 245 citations Sabine Daemen, Anastasiia Gainullina et al. Cell Reports profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ariel E. Feldstein 17.2k 9.2k 6.7k 6.3k 4.2k 220 26.9k
Quentin M. Anstee 19.7k 1.1× 4.0k 0.4× 7.9k 1.2× 8.9k 1.4× 3.0k 0.7× 254 23.9k
Geoffrey C. Farrell 19.9k 1.2× 4.7k 0.5× 6.9k 1.0× 10.0k 1.6× 2.6k 0.6× 213 26.1k
Elisabetta Bugianesi 27.9k 1.6× 5.4k 0.6× 12.9k 1.9× 10.6k 1.7× 4.8k 1.1× 298 33.3k
Christopher P. Day 23.0k 1.3× 4.1k 0.4× 9.9k 1.5× 10.2k 1.6× 3.1k 0.7× 186 31.1k
Arthur J. McCullough 28.2k 1.6× 5.5k 0.6× 12.0k 1.8× 12.0k 1.9× 5.4k 1.3× 293 35.4k
Michael Charlton 19.5k 1.1× 3.1k 0.3× 6.2k 0.9× 12.9k 2.0× 2.6k 0.6× 250 25.3k
Mark L. Van Natta 14.7k 0.9× 2.6k 0.3× 5.5k 0.8× 6.3k 1.0× 2.8k 0.7× 111 19.2k
Leon A. Adams 18.9k 1.1× 2.9k 0.3× 7.9k 1.2× 9.1k 1.4× 2.4k 0.6× 202 22.9k
Craig J. McClain 11.2k 0.6× 8.4k 0.9× 3.8k 0.6× 3.3k 0.5× 4.1k 1.0× 576 28.9k
Claudio Tiribelli 10.6k 0.6× 5.8k 0.6× 3.9k 0.6× 5.5k 0.9× 1.6k 0.4× 403 19.9k

Countries citing papers authored by Ariel E. Feldstein

Since Specialization
Citations

This map shows the geographic impact of Ariel E. Feldstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariel E. Feldstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariel E. Feldstein more than expected).

Fields of papers citing papers by Ariel E. Feldstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ariel E. Feldstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariel E. Feldstein. The network helps show where Ariel E. Feldstein may publish in the future.

Co-authorship network of co-authors of Ariel E. Feldstein

This figure shows the co-authorship network connecting the top 25 collaborators of Ariel E. Feldstein. A scholar is included among the top collaborators of Ariel E. Feldstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ariel E. Feldstein. Ariel E. Feldstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaufmann, Benedikt, Laela M. Booshehri, Janset Onyuru, et al.. (2023). Antisense Oligonucleotide Therapy Decreases IL-1β Expression and Prolongs Survival in Mutant Nlrp3 Mice. The Journal of Immunology. 211(2). 287–294. 6 indexed citations
2.
Kaufmann, Benedikt, et al.. (2023). Myeloid-specific deletion of chitinase-3-like 1 protein ameliorates murine diet-induced steatohepatitis progression. Journal of Molecular Medicine. 101(7). 813–828. 7 indexed citations
3.
Leszczynska, Aleksandra, et al.. (2023). Pyroptosis and gasdermins—Emerging insights and therapeutic opportunities in metabolic dysfunction-associated steatohepatitis. Frontiers in Cell and Developmental Biology. 11. 1218807–1218807. 8 indexed citations
4.
Daemen, Sabine, Anastasiia Gainullina, Gowri Kalugotla, et al.. (2021). Dynamic Shifts in the Composition of Resident and Recruited Macrophages Influence Tissue Remodeling in NASH. Cell Reports. 34(2). 108626–108626. 245 indexed citations breakdown →
5.
Name, Michelle Van, Mary Savoye, Ariel E. Feldstein, et al.. (2020). A Low ω-6 to ω-3 PUFA Ratio (n–6:n–3 PUFA) Diet to Treat Fatty Liver Disease in Obese Youth. Journal of Nutrition. 150(9). 2314–2321. 57 indexed citations
6.
Eguchi, Akiko, Enis Kostallari, Ariel E. Feldstein, & Vijay H. Shah. (2019). Extracellular vesicles, the liquid biopsy of the future. Journal of Hepatology. 70(6). 1292–1294. 53 indexed citations
7.
Maricic, Igor, Idania Marrero, Akiko Eguchi, et al.. (2018). Differential Activation of Hepatic Invariant NKT Cell Subsets Plays a Key Role in Progression of Nonalcoholic Steatohepatitis. The Journal of Immunology. 201(10). 3017–3035. 78 indexed citations
8.
Mann, Jelena, Helen L. Reeves, & Ariel E. Feldstein. (2018). Liquid biopsy for liver diseases. Gut. 67(12). 2204–2212. 77 indexed citations
9.
Mridha, Auvro R., Alexander Wree, Avril A. B. Robertson, et al.. (2017). NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. Journal of Hepatology. 66(5). 1037–1046. 863 indexed citations breakdown →
10.
Johnson, Casey D., Alexander Wree, Davide Povero, et al.. (2016). Hepatic Stellate Cell Specific NLRP3 Inflammasome Activation Results in Spontaneous Fibrosis. RWTH Publications (RWTH Aachen). 1 indexed citations
11.
Goffredo, Martina, Sonia Caprio, Ariel E. Feldstein, et al.. (2015). Role of TM6SF2 rs58542926 in the pathogenesis of nonalcoholic pediatric fatty liver disease: A multiethnic study. Hepatology. 63(1). 117–125. 107 indexed citations
12.
Patel, N., Michael R. Peterson, Grace Lin, et al.. (2013). Insulin Resistance Increases MRI-Estimated Pancreatic Fat in Nonalcoholic Fatty Liver Disease and Normal Controls. Gastroenterology Research and Practice. 2013. 1–8. 48 indexed citations
13.
Lazić, Miloš, Davide Povero, Yury I. Miller, et al.. (2013). 1271 REDUCED DIETARY OMEGA-6:OMEGA-3 RATIO AND 12/15-LIPOXYGENASE DEFICIENCY PROTECT FROM HIGH FAT DIET-INDUCED STEATOHEPATITIS. Journal of Hepatology. 58. S514–S514. 1 indexed citations
14.
Santoro, Nicola, Sonia Caprio, Cosimo Giannini, et al.. (2013). Oxidized Fatty Acids: A Potential Pathogenic Link Between Fatty Liver and Type 2 Diabetes in Obese Adolescents?. Antioxidants and Redox Signaling. 20(2). 383–389. 36 indexed citations
15.
Berk, Michael, et al.. (2013). Stearoyl-CoA desaturase plays an important role in proliferation and chemoresistance in human hepatocellular carcinoma. Journal of Surgical Research. 186(1). 29–38. 65 indexed citations
16.
Roychowdhury, Sanjoy, Dian Chiang, Palash Mandal, et al.. (2012). Inhibition of Apoptosis Protects Mice from Ethanol‐Mediated Acceleration of Early Markers of CC l 4 ‐Induced Fibrosis but not Steatosis or Inflammation. Alcoholism Clinical and Experimental Research. 36(7). 1139–1147. 64 indexed citations
17.
Feldstein, Ariel E. & Shannon M. Bailey. (2011). Emerging Role of Redox Dysregulation in Alcoholic and Nonalcoholic Fatty Liver Disease. Antioxidants and Redox Signaling. 15(2). 421–424. 40 indexed citations
18.
Alkhouri, Naim, Agnieszka Górnicka, Michael Berk, et al.. (2009). Adipocyte Apoptosis, a Link between Obesity, Insulin Resistance, and Hepatic Steatosis. Journal of Biological Chemistry. 285(5). 3428–3438. 307 indexed citations
19.
Carter‐Kent, Christine, Nizar N. Zein, & Ariel E. Feldstein. (2008). Cytokines in the Pathogenesis of Fatty Liver and Disease Progression to Steatohepatitis: Implications for Treatment. The American Journal of Gastroenterology. 103(4). 1036–1042. 167 indexed citations
20.
Romero, J. Carlos, et al.. (1999). New methods to investigate the intrarenal distribution of blood flow and tubular fluid flow dynamics. Current Opinion in Nephrology & Hypertension. 8(2). 157–166. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Quentin M. Anstee Breakdown of academic impact, for papers by Geoffrey C. Farrell Breakdown of academic impact, for papers by Elisabetta Bugianesi Breakdown of academic impact, for papers by Christopher P. Day Breakdown of academic impact, for papers by Arthur J. McCullough Breakdown of academic impact, for papers by Michael Charlton Breakdown of academic impact, for papers by Mark L. Van Natta Breakdown of academic impact, for papers by Leon A. Adams Breakdown of academic impact, for papers by Craig J. McClain Breakdown of academic impact, for papers by Claudio Tiribelli
Rankless by CCL
2026